Related Experiment Video
Updated: Aug 20, 2026

Disposable Dosators Intended for Dry Powder Delivery to Mice
Published on: August 18, 2023
Inhaled steroid delivery from small-volume holding chambers depends on age, holding chamber, and interface in
Jean-Christophe Dubus1, Jacob Anhøj
1Unité de Médecine Infantile, CHU Timone-Enfants, Marseille, France. jean-christophe.dubus@ap-hm.fr
Insights
Inhaled steroid delivery via holding chambers significantly increases with patient age. Device choice and inhalation interface (mask vs. mouthpiece) also impact drug delivery for asthma patients.
Area of Science:
- Respiratory Medicine
- Pediatric Pulmonology
- Pharmacology
Background:
- Pressurized metered-dose inhalers (pMDIs) with holding chambers are common for delivering inhaled corticosteroids (ICS) to children.
- Optimal drug delivery is crucial for managing pediatric asthma effectively.
- Factors influencing ICS delivery, such as patient age and device interface, require further investigation.
Purpose of the Study:
- To investigate the relationship between patient age, holding chamber type, and inhalation interface on the delivery of inhaled steroids from pMDIs.
- To quantify the amount of inhaled steroid reaching the filter (proxy for lung deposition) across different age groups and device configurations.
Main Methods:
- An open, randomized, cross-over filter study was conducted with 4 groups of children (infants to adolescents) with varying asthma severity.
- Budesonide (Nebuchamber) and fluticasone propionate (Babyhaler) were administered via pMDIs with their respective holding chambers.
- Drug delivery was measured using filters, analyzed by high-performance liquid chromatography, and modeled using mixed-effects linear regression.
Main Results:
- Inhaled steroid delivery significantly increased with age for both holding chambers, from 3-7% in infants to 40-41% in adolescents.
- Nebuchamber showed higher drug delivery than Babyhaler (p=0.002).
- Using a mouthpiece resulted in lower filter doses compared to a facemask for both devices (p<0.0001).
Conclusions:
- Inhaled steroid delivery from pMDIs with holding chambers is significantly influenced by patient age, holding chamber type, and inhalation interface.
- These findings highlight the need for age-appropriate device selection and interface use in pediatric asthma management.
- Further clinical studies are warranted to compare lung deposition and clinical outcomes between mouthpiece and facemask inhalation from holding chambers.
Abstract:
The relationship between the amount of inhaled steroids delivered from pressurized metered-dose inhalers used with their recommended holding chambers and age of the patients using these devices was studied in an open randomised cross-over filter study. We recruited 1-2-month-old healthy infants (n = 21), 2-3-year-old asthmatics (n = 13), 4-6-year-old asthmatics (n = 15), and 10-15-year-old asthmatics (n = 20). Each child inhaled two puffs, administered by a single investigator, of both budesonide through Nebuchamber and fluticasone propionate through Babyhaler, on two occasions. Moreover, the 4-6-year-old group inhaled via both facemask and mouthpiece. Drug, collected on a filter interposed between holding chamber and patient, was analysed by high performance liquid chromatography. Filter dose, expressed in percent of the nominal dose, was analysed in a mixed effect linear regression model with age group, holding chamber and inhalation interface (facemask or mouthpiece) as fixed effects and subject as random effect. Filter dose from both holding chambers increased significantly with age, from 3% with Babyhaler and 7% with Nebuchamber in the youngest children, to 40-41% with both holding chambers in adolescents. Nebuchamber delivered more drug than Babyhaler (p = 0.002), but variability in drug delivery (about 11%) was similar between holding chambers. Filter dose decreased from 35% to 22% with Babyhaler, and from 42% to 27% with Nebuchamber when using a mouthpiece rather than a facemask (p < 0.0001). Delivery of inhaled steroids used with their recommended holding chambers depends from age and holding chamber, but also from the inhalation interface. Lung deposition and clinical studies comparing inhalation from holding chambers with mouthpiece and facemask are urgently required.
Related Concept Videos
Inhaled Medications
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Ophthalmic Drug Delivery Systems
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

